No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

about

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

Item

http://www.wikidata.org/entity/Q58797266

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@en

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@nl

type

Item

label

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@en

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@nl

prefLabel

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@en

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@nl

P1476

No Effect of Dose Adjustment to the Genotype in Patients With Severe Mental Illness

@en

P2093

Anne B Koopmans

http://www.w3.org/2001/XMLSchema#string

David J Vinkers

http://www.w3.org/2001/XMLSchema#string

Hans W Hoek

http://www.w3.org/2001/XMLSchema#string

Igmar T Poulina

http://www.w3.org/2001/XMLSchema#string

Peter N van Harten

http://www.w3.org/2001/XMLSchema#string

Petra J A Gelan

http://www.w3.org/2001/XMLSchema#string

Ron H N van Schaik

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for drug-induced akathisia

A systematic review of the effects of antipsychotic drugs on brain volume.

Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness.

Pharmacogenetics: from bench to byte--an update of guidelines.

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotype

Developing the World Health Organization Disability Assessment Schedule 2.0.

Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis

Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder Clinic.

Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.

P304

349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPSYT.2018.00349

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30131727

http://www.w3.org/2001/XMLSchema#string

P932

6090167

http://www.w3.org/2001/XMLSchema#string